Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Brooks

Showing results (1131-1140 of 1,175) with videos related to

Pageof 118
Sort By:
Journal of Translational Medicine|April 24, 2024
AZGP1 deficiency promotes angiogenesis in prostate cancerRu M Wen, Zhengyuan Qiu, G Edward W Marti, et al.
The American Journal of Surgical Pathology|September 17, 2016
Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized: Analysis of the Relative Prognostic Strength of Individual Architectural Patterns in 1275 Patients From the Canary Retrospective CohortJesse K McKenney, Wei Wei, Sarah Hawley, et al.
Journal of the National Cancer Institute|March 3, 2020
Radiation Treatment, ATM, BRCA1/2, and CHEK2*1100delC Pathogenic Variants and Risk of Contralateral Breast CancerAnne S Reiner, Mark E Robson, Lene Mellemkjær, et al.
Elife|September 9, 2016
Two locus inheritance of non-syndromic midline craniosynostosis via rare <i>SMAD6</i> and common <i>BMP2</i> allelesAndrew T Timberlake, Jungmin Choi, Samir Zaidi, et al.
Journal of Medicinal Chemistry|June 20, 1997
Structure-activity relationships of N-hydroxyurea 5-lipoxygenase inhibitorsA O Stewart, P A Bhatia, J G Martin, et al.
Translational Oncology|September 30, 2021
The induction of a mesenchymal phenotype by platelet cloaking of cancer cells is a universal phenomenonCathy D Spillane, Niamh M Cooke, Mark P Ward, et al.
Plos Genetics|March 22, 2024
Canadian COVID-19 host genetics cohort replicates known severity associationsElika Garg, Paola Arguello-Pascualli, Olga Vishnyakova, et al.
Journal of Personalized Medicine|August 27, 2021
Risk-Stratified Approach to Breast Cancer Screening in Canada: Women's Knowledge of the Legislative Context and Concerns about Discrimination from Genetic and Other Predictive Health DataSamuel Alarie, Julie Hagan, Gratien Dalpé, et al.
Plos Genetics|March 4, 2025
Correction: Canadian COVID-19 host genetics cohort replicates known severity associationsElika Garg, Paola Arguello-Pascualli, Olga Vishnyakova, et al.
Histopathology|June 3, 2024
Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stageJane K Nguyen, Lara R Harik, Eric A Klein, et al.
Pageof 118

Showing results (1131-1140 of 1,175) with videos related to

Sort By:
Pageof 118
Journal of Translational Medicine|April 24, 2024
AZGP1 deficiency promotes angiogenesis in prostate cancerRu M Wen, Zhengyuan Qiu, G Edward W Marti, et al.
The American Journal of Surgical Pathology|September 17, 2016
Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized: Analysis of the Relative Prognostic Strength of Individual Architectural Patterns in 1275 Patients From the Canary Retrospective CohortJesse K McKenney, Wei Wei, Sarah Hawley, et al.
Journal of the National Cancer Institute|March 3, 2020
Radiation Treatment, ATM, BRCA1/2, and CHEK2*1100delC Pathogenic Variants and Risk of Contralateral Breast CancerAnne S Reiner, Mark E Robson, Lene Mellemkjær, et al.
Elife|September 9, 2016
Two locus inheritance of non-syndromic midline craniosynostosis via rare <i>SMAD6</i> and common <i>BMP2</i> allelesAndrew T Timberlake, Jungmin Choi, Samir Zaidi, et al.
Journal of Medicinal Chemistry|June 20, 1997
Structure-activity relationships of N-hydroxyurea 5-lipoxygenase inhibitorsA O Stewart, P A Bhatia, J G Martin, et al.
Translational Oncology|September 30, 2021
The induction of a mesenchymal phenotype by platelet cloaking of cancer cells is a universal phenomenonCathy D Spillane, Niamh M Cooke, Mark P Ward, et al.
Plos Genetics|March 22, 2024
Canadian COVID-19 host genetics cohort replicates known severity associationsElika Garg, Paola Arguello-Pascualli, Olga Vishnyakova, et al.
Journal of Personalized Medicine|August 27, 2021
Risk-Stratified Approach to Breast Cancer Screening in Canada: Women's Knowledge of the Legislative Context and Concerns about Discrimination from Genetic and Other Predictive Health DataSamuel Alarie, Julie Hagan, Gratien Dalpé, et al.
Plos Genetics|March 4, 2025
Correction: Canadian COVID-19 host genetics cohort replicates known severity associationsElika Garg, Paola Arguello-Pascualli, Olga Vishnyakova, et al.
Histopathology|June 3, 2024
Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stageJane K Nguyen, Lara R Harik, Eric A Klein, et al.
Pageof 118